REGISTER BY FEBRUARY 10 FOR EARLY EVENT PLATFORM ACCESS
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Wenzhong GuoCTO, Cell Therapy at Sorrento Therapeutics, USA
Profile
Dr. Guo is the CTO of Cell Therapy in Sorrento Therapeutics Inc and has ~30 years of research and product development experience in Tumor Immunology, antibody drug development and T/NK cell Therapy. He is leading non-viral vector CAR/DAR-T cell therapy product development including R&D, process development and manufacturing in Sorrento. Dr. Guo obtained his Ph.D. in Tumor Immunology from State Key lab of Molecular Oncology of Chinese Academy of Medical Sciences and did tumor immunology research in M.D. Anderson Cancer Center in Houston and National Jewish Health in Denver. He has over 10 years- experience in cell therapy industry.
Agenda Sessions
Non-Viral Vector Engineered Allogeneic T Cell Therapies Utilizing a Novel Dimeric Antigen Receptor (DAR) Structure
, 1:30pmView Session